Dr Cheryl Keech | Chief Medical Officer And Executive Vice President Of Clinical Research
ILiAD Biotechnologies, LLC

Dr Cheryl Keech, Chief Medical Officer And Executive Vice President Of Clinical Research, ILiAD Biotechnologies, LLC

Appearances:



Day 2, April 8 @ 11:40

Results from the Ph2 trial of BPZE1 intranasal pertussis vaccine in healthy adults - Assessing immunity and safety using a prime or prime+boost schedule

last published: 05/Mar/20 10:35 GMT

back to speakers

Sign Up for Event Updates